Cost-Sharing Incentives Would Drive Higher Generic Drug Use By Low-Income Enrollees In Part D - MedPAC

Staff analysis found beneficiaries receiving subsidies have high brand use in categories where generics are available, including antipsychotics, diabetes, peptic ulcer treatment, cholesterol therapy.